Halozyme Falls on Phase II Study Halt – Analyst Blog
Halozyme Therapeutics, Inc. ‘s ( HALO ) shares fell 27.3% after the company announced its decision to temporarily halt patient …read more
Halozyme Therapeutics, Inc. ‘s ( HALO ) shares fell 27.3% after the company announced its decision to temporarily halt patient …read more
On April 4, we have issued an updated research report on Alliant Techsystems Inc. ( ATK ). The U.S. aerospace …read more
3D printing solutions provider, Stratasys Ltd. ( SSYS ) is on an acquisition spree. Following the acquisition of two privately …read more
Short messaging microblogging service provider Twitter ( TWTR ) recently announced the acquisition of an Android lock screen app named …read more
The S&P 500 essentially has been flat year to date. But that doesn’t mean there haven’t been winners and losers …read more
The Coca Cola Company ( KO ) leads the U.S. carbonated soft drinks ( CSD ) category, with almost one …read more
While Wal Mart’s ( WMT ) domestic business has struggled over the last one year, its international business hasn’t done …read more
Itau Unibanco Holding SA ( ITUB ) is looking like an interesting pick from a technical perspective, as the company …read more
API Technologies Corp ( ATNY ) could be a stock to avoid from a technical perspective, as the firm is …read more
Pinnacle Entertainment, Inc ( PNK ) could be a stock to avoid from a technical perspective, as the firm is …read more